UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden

hours per response:

0.5

1. Name and Address of Reporting Person*Chadwick Christopher M

(Last)

(First)

(Middle)

100 N. RIVERSIDE PLAZA

M/C 5003-1001

(Street)

CHICAGO

IL

60606

(City)

(State)

(Zip)

2. Date of Event Requiring Statement

(Month/Day/Year)

12/31/2013

3. Issuer Name and Ticker or Trading Symbol

BOEING CO

[ BA ]

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

Director

10% Owner

Officer (give title below)

Other (specify below)

EVP, Pres. & CEO, BDS

5. If Amendment, Date of Original Filed

(Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr.

4)

2.

Amount of Securities Beneficially Owned (Instr.

4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

4. Nature of Indirect Beneficial Ownership (Instr.

5)

Common Stock

32,335.73(1)

Common Stock

1,005.4

By 401(k)

Common Stock

2,040.08

Career Shares

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.

4)

2. Date Exercisable and Expiration Date

(Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr.

4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

6. Nature of Indirect Beneficial Ownership (Instr.

5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Deferred Compensation Units

(2)

(2)

Common Stock

11,666.38

(2)

Phantom Stock Units

(3)

(3)

Common Stock

1,810.69

(3)

Stock Option (Right to Buy)

(4)

02/22/2021

Common Stock

13,898

$71.435

Stock Option (Right to Buy)

(5)

02/27/2022

Common Stock

16,199

$75.395

Stock Option (Right to Buy)

(6)

02/25/2023

Common Stock

19,321

$75.965

Stock Option (Right to Buy)

(7)

02/25/2018

Common Stock

10,100

$83.93

Stock Option (Right to Buy)

(8)

02/26/2017

Common Stock

8,700

$89.645

Explanation of Responses:

1. Includes an aggregate of 32,323.73 restricted stock units of which 3,714.12 will vest on February 22, 2014, 24,526.20 will vest on February 27, 2015 and 4,083.41 will vest on February 25, 2016; restricted stock units settle in shares of the issuer's common stock on a one-for-one basis.

2. Each deferred compensation unit is convertible into one share of the issuer's common stock or the economic equivalent thereof. Deferred compensation units are payable in stock or cash at the election of the holder following the holder's termination of employment with the issuer, except that (i) company matching deferred stock units are payable only in stock and are forfeited upon termination for any reason other than retirement, death, disability or layoff and (ii) units acquired upon deferral of certain performance shares are payable only in stock.

3. Each phantom stock unit is the economic equivalent of one share of the issuer's common stock. The reported phantom stock units were acquired under the issuer's excess benefit plan and are to be settled following the reporting person's termination of service with the issuer.

4. Represents an option for the purchase of 13,898 shares vesting over a period of three years from the date of grant (February 22, 2011), with 34% vesting on February 22, 2012, 33% vesting on February 22, 2013, and 33% vesting on February 22, 2014.

5. Represents an option grant for the purchase of 16,199 shares vesting over a period of three years from the date of grant (February 27, 2012), with 34% on February 27, 2013, 33% on February 27, 2014 and 33% on February 27, 2015.

6. Represents an option grant for the purchase of 19,321 shares vesting over a period of three years from the date of grant (February 25, 2013), with 34% on February 25, 2014, 33% on February 25, 2015 and 33% on February 25, 2016.

7. The option was fully vested on February 25, 2011.

8. The option was fully vested on February 26, 2010.

Remarks:

chadwickpoa.txt

/s/ Gregory C. Vogelsperger, Attorney-in-Fact

01/06/2014

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,

see

Instruction

(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see

Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.